Navigation Links
Omeros Corporation Reports First Quarter 2013 Financial Results
Date:5/10/2013

SEATTLE, May 10, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the first quarter of 2013.

Financial ResultsTotal operating expenses for the quarter ended March 31, 2013 were $11.1 million compared to $9.6 million for the same period in 2012. The increase is primarily due to research and development expenses associated with advancing Omeros' MASP-2 program toward the clinic, employee costs and non-cash rent expense, and to selling, general and administrative expenses related to legal matters and Omeros' planned commercial launch of OMS302 in 2014.  These higher costs were partially offset by lower clinical trial expenses related to the completion of Phase 3 clinical trials for Omeros' OMS302 and OMS103HP programs in January 2013 and December 2012, respectively.  For the quarter ended March 31, 2013, Omeros reported a net loss of $10.5 million, or $0.40 per share, compared to a net loss of $8.9 million, or $0.40 per share, for the same period in 2012.

At March 31, 2013, Omeros had cash, cash equivalents and short-term investments of $13.3 million. On May 9, Omeros announced that it priced a public offering of 3,903,004 shares of its common stock at a price of $4.14 per share, a two percent premium over the closing price on May 8, 2013, for estimated net proceeds of $16.1 million. The offering is expected to close on or about May 14, 2013. The shares were offered and are expected to be sold to RA Capital Management and other investors in a registered direct offering conducted without an underwriter or placement agent. Omeros also did not use its at-the-market sales facility or its committed
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
2. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
3. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
4. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
5. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
6. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
7. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
8. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
9. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
10. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
11. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Calif. , March 2, 2015  Kush ... supplier of child-resistant packaging solutions for the marijuana ... Nicholas Kovacevich , has been nominated for a ... The Excellence in Entrepreneurship Award is designed to ... – individuals who, by their creativity and determination, ...
(Date:3/2/2015)... 2, 2015  Maquet Medical Systems ... signed an exclusive distribution agreement with Flight Medical ... the Flight 60 mechanical ventilator. The Flight 60 ... and affordable mobility. Starting in the first quarter ... in the United States ...
(Date:3/2/2015)... , March 2, 2015 ... the population with nearly 38,000 of those ... Staphylococcus Aureus), a highly contagious disease, infects ... deaths.  Each of these and more, not ... through casual contact with other infectious individuals, ...
Breaking Medicine Technology:Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 2Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 3
(Date:3/2/2015)... York, NY (PRWEB) March 02, 2015 ... Drug Administration (FDA) warned against the use of ... hysterectomies and fibroid removal surgeries, insurer UnitedHealthCare is ... the use of those devices. In a notification ... that beginning in April, it would require pre-authorization ...
(Date:3/2/2015)... March 02, 2015 ZoomCare announced ... remake American healthcare. Zoom will expand its Portland ... clinics and advanced care studios delivering urgent care, ... services, specialty care and outpatient surgery. With its ... to almost all healthcare needs outside of hospitalization. ...
(Date:3/2/2015)... New York (PRWEB) March 02, 2015 ... Recovery at Recovery Unplugged™—will be delivering a plenary ... Singer/Songwriter's Perspective on the Art of Healing and ... Disorders (NCAD) and Behavioral Healthcare Executive Summit (BHES).     ... name, Mr. Supa’s songs have been recorded by ...
(Date:3/2/2015)... NY (PRWEB) March 02, 2015 This year, ... March 2–8 and will provide opportunities for people across the ... ways to help people with MS live their best lives. ... made and to inspire others to join the Society’s vision ... sclerosis, an unpredictable, often disabling disease of the central nervous ...
(Date:3/2/2015)... 2015 Regulatory Compliance Associates® Inc. ... regulatory and technical consulting, announces Mr. Seyed Khorashahi ... , Before joining RCA, Mr. Khorashahi had ... in all aspects of developing safety-critical medical devices. ... (Medtronic), Regulatory Compliance Associates Inc., Baxter Healthcare, and ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2
... which expands into Optical Coherence Tomography. This breakthrough has made ... angioplasty. This has been developed by Dr. Brett Bouma an ... coherence tomography to gauge stent status.// , ... to ultrasound and will allow cardiologists to view the status ...
... wounds and wound healing has always been difficult terrain for ... processes and understanding inter cellular mechanisms is the key to ... Researchers led by Vito Quaranta at ... integrin-a protein that helps trigger the healing process -- also ...
... parathyroid hormone (parathormone) increases the patient’s bone density and cut the ... in regulating calcium levels in the body. , ... fractures has opened up the prospect of the hormone being used ... known as.// , The ...
... discovered in plants, has been pin pointed in humans as being ... The chances of developing an inherited form of the diseases increases ... on chromosome 16. , ... and USA. The complete data will appear in the May 31st ...
... 24th issue of Nature reveals that the Obesity Hormone – ... more complex way than previously believed. This break through has ... and many nutrition related disorders like anorexia nervosa. Dr. Malcolm ... the study. , ...
... Clinic created a break through in ENT surgery by conducting ... recipient of the transplant is not able to speak with ... the motorcycle accident. He had been unable to speak normally ... speeches to other patients and support groups. , ...
Cached Medicine News:
Shandon Microscope Slide Trays...
... is the first solid-state,photocoagulator to ... wavelengths. This advanced,laser system makes ... a red or green wavelength,during ... and ensures effective,patient results., For ...
... Gathering, managing, and transmitting data ... you were hired for. Dawnings ResultNet/Plus ... running your lab, not your communications ... with transmitting result data from largescale ...
... Horizon Cardiology Hemo is a comprehensive ... for the cath lab. Patient ... cardiac images and procedural information all ... patient record, eliminating repetitive data entry. ...
Medicine Products: